D918BCZLow Dose Rate (LDR) Brachytherapy of Hard Palate using Californium 252 (Cf-252)
- Billable / Specific Code
D918BCZ is a billable ICD-10-PCS procedure code for Low Dose Rate (LDR) Brachytherapy of Hard Palate using Californium 252 (Cf-252). It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026).
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | D | Radiation Therapy |
| 2 | Body System | 9 | Ear, Nose, Mouth and Throat |
| 3 | Modality | 1 | Brachytherapy |
| 4 | TreatmentSite | 8 | Hard Palate |
| 5 | ModalityQualifier | B | Low Dose Rate (LDR) |
| 6 | Isotope | C | Californium 252 (Cf-252) |
| 7 | Qualifier | Z | None |
Convert to ICD-9-PCS
Closest ICD-9-PCS equivalents for D918BCZ under the General Equivalence Mappings.
Similar Procedure Codes
Questions About D918BCZ
Is D918BCZ a billable code?
Yes. D918BCZ is a complete seven-character ICD-10-PCS code, specific enough to report Low Dose Rate (LDR) Brachytherapy of Hard Palate using Californium 252 (Cf-252) on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in D918BCZ mean?
D918BCZ breaks down character by character: the 1st character D is the Section (Radiation Therapy); the 2nd character 9 is the Body System (Ear, Nose, Mouth and Throat); the 3rd character 1 is the Modality (Brachytherapy); the 4th character 8 is the TreatmentSite (Hard Palate); the 5th character B is the ModalityQualifier (Low Dose Rate (LDR)); the 6th character C is the Isotope (Californium 252 (Cf-252)); the 7th character Z is the Qualifier (None).
What is the ICD-9-PCS equivalent of D918BCZ?
Under the General Equivalence Mappings, Low Dose Rate (LDR) Brachytherapy of Hard Palate using Californium 252 (Cf-252) crosswalks to ICD-9-PCS 92.23. The mapping is approximate, so confirm it fits the documentation.
